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Abstract
Primary undifferentiated embryonal sarcoma of the liver is a rare tumor with a peak incidence between the ages of
6 and 10 years. We report a case of a primary hepatic undifferentiated embryonal sarcoma arising in a 21-year-old
male mistaken for hydatid disease of the liver. The rapid recurrence of this tumor along the site of attempted per-
cutaneous drainage illustrates some important management points regarding this malignancy.
Introduction
Primary undifferentiated embryonal sarcoma (UES) of
the liver is a rare and highly malignant neoplasm of
mesenchymal origin. The majority of primary hepatic
malignancies are carcinomas with primary hepatic sarco-
mas representing between 0.1% and 2% of primary hepa-
tic cancers [1]. UES of the liver is most commonly seen
arising in children with a peak incidence between 6 and
10 years but can arise in adults [2].
Our institution is a leading tertiary referral centre for
the treatment of hepatic malignancies in the region.
From 1998 to 2009, 215 adult patients were diagnosed
with primary hepatic malignancies at our institution, 4
of which were diagnosed with primary hepatic sarcoma
(1.8%). Three cases were primary hepatic leiomyosarco-
mas (LMS) and one case was primary UES of the liver
mistaken for hydatid disease in a 21-year-old male
patient. Hydatid disease is endemic in the Middle East
and is top of the differential diagnosis for a cystic liver
lesion presenting in this age group.
Case Report
A 21 year old male patient was referred to our institu-
tion following unsuccessful surgery for presumed hyda-
tid disease of the right lobe of the liver. The initial
operation was performed in a district hospital; an open
approach was performed and an attempt to drain/resect
the lesion failed. The operation was aborted and a per-
cutaneous drain was inserted at the site of surgery. The
patient was in hospital for 2 weeks with no
improvement. The family decided to transfer him to our
institution which is a tertiary care center specialized in
hepatobiliary surgery.
On admission, the patient was in respiratory distress
with severe abdominal pain, distension and lower limb
edema. The alpha-fetoprotein (AFP) at the time of diag-
nosis was 3.6 U/mL (range 1-9), carcinoembryonic Ag
(CEA) 2.2 ng/mL (range 0-4) and human chorionic
gonadotropin (Beta- HCG) 3.6 mlU/mL (< = 4). The
laboratory tests included INR median 1.4 (range 0.9-
1.1), serum bilirubin (Total) 1.4 mg/dL (range 0-1.2),
serum aspartate aminotransferase (AST) 113 IU/L
(range 0-50), gamma-glutamyl transferase 95 IU/L
(range 0-50), creatinine 0.6 mg/dL (range 0.5-1.2), plate-
let count 680 × 10
9/L (range 150-400) and haemoglobin
11 g/dl (range 13-18). ELISA test was negative for hyda-
tid disease Serology was negative for hepatitis B, C and
HIV.
A computed tomography (CT) scan of the abdomen
revealed a large, well defined lesion with intracystic sep-
tations occupying the right hepatic lobe measuring 22 ×
19 × 23.6 cm containing the percutaneous drain (Figure
1). Significant abdominal ascites was noted.
A technically challenging extended right hepatectomy
was performed. Histopathology revealed an unusual neo-
plasm composed of irregular spindle cells showing mod-
erate pleomorphism and brisk mitotic activity (Figure 2).
Immunohistochemical studies showed positive staining
for vimentin and a positive cytokeratin AE1/3. Diagnosis
was made of a stage III undifferentiated embryonic sar-
coma (UES). The patient was discharged home day 16
post-resection. Adjuvant chemotherapy was recom-
mended and the patient elected to be treated in his
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sented to our institution with a fungating abdominal
wall mass at the site of previous percutaneous drain
insertion. CT scan revealed a new lesion in segment II
and an intra-abdominal lesion extending through the
drain site 5 cm outside the skin (Figure 3). The skin
lesion was resected and histopathological examination
revealed metastatic UES. He elected to go back to his
country of origin where he received adjuvant
chemotherapy which was ifosfamide plus etoposide
alternating with actinomycin-D, vincristine every 3
weeks for 6 months. He is currently 5 months post-
resection and a recent CT scan showed no evidence of
disease recurrence.
Discussion
Diagnosis of primary hepatic sarcoma is challenging due
to the lack of specific presenting symptoms, lack of ser-
ological markers, non-specific findings on radiological
imaging and the rarity of the disease. Pachera et al
recently reviewed the literature on primary hepatic UES
and found that in the past 50 years only 51 cases have
been reported in patients older than 15 years [3]. UES
often show a misleading cystic appearance on CT and
magnetic resonance imaging (MRI) in contrast to a pre-
dominantly solid appearance on ultrasound [4]. This
finding may help to avoid attempts at drainage as in the
case we have presented. In their literature review,
Pachera et al found that the diagnosis of UES was
delayed in 12 cases (23.5%) where the presentation with
large cystic hepatic mass was suggestive of a benign
lesion. There have been previous case reports of hepatic
UES being mistaken for hydatid disease [5-8] however
this is the first report of a case in which the diagnosis
was made after attempted percutaneous drainage with
evidence of rapid track-seeding and progression post-
resection.
Hydatid disease is a common pathology in our region
and the surgical options are numerous. Surgeons may
opt to remove the cysts through an open approach or
laparoscopic approach. In either approach, it should be
Figure 1 A computed tomography (CT) scan of the abdomen
with a large lesion occupying the right hepatic lobe.
Figure 2 Histopathology of the UES of the liver with irregular
spindle cells showing moderate pleomorphism and brisk
mitotic activity.
Figure 3 Intra-abdominal lesion extending through the drain
site 5 cm outside the skin.
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one should be taken. With regards to open surgery, sev-
eral recent studies have shown that the radical approach
is associated with lower rates of recurrence, fewer com-
plications such as bile leak and decreased mortality. Per-
cutaneous drainage of hydatid disease is another option,
but we try to avoid this due to the risk of intra-abdom-
inal spillage.
In our institution, both open and laparascopic proce-
dures are performed and the choice of approach
depends on the size and location of the hydatid lesion
[9-11].
Complete resection followed by adjuvant chemother-
apy is the current standard of care for hepatic UES,
however due to the rarity of the disease, limited data
exists and treatment remains largely empirical. Positive
resection margins and spontaneous or iatrogenic rupture
of the tumour are associated with early recurrence and
death [3]. Lenze et al reviewed treatment outcomes for
68 patients over the age of 15 years and found a median
survival of 29 months. Patients who underwent com-
plete resection followed by adjuvant chemotherapy had
significantly better survival compared with patients who
underwent surgical resection alone. As expected, incom-
plete resection was associated with poorer outcome [12].
There have been three reports of liver transplantation
for UES in children [13-15] however the use of liver
transplantation for primary hepatic sarcoma in adults is
controversial. There are no reports of liver transplanta-
tion for UES in adults and outcomes of liver transplan-
tation for other histological subtypes such as hepatic
angiosarcoma and LMS have been disappointing [16,17].
The case we have presented demonstrates the propen-
sity of this tumour to rapidly recur along a percutaneous
track however tumour control was achieved with a sec-
ond radical resection followed by adjuvant
chemotherapy.
Conclusion
In summary, this case illustrates some important aspects
of this rare disease:
1. The discrepancy between CT and ultrasound
appearances of this lesion is a key factor that should
raise the index of suspicion when noted.
2. Due to the propensity of this lesion to seed along
a percutaneous track, percutaneous biopsy or percu-
taneous drainage should not be attempted.
3. Complete resection must be attempted including
resection of any potential percutaneous track fol-
lowed by adjuvant chemotherapy.
4. If a percutaneous track cannot be resected, radio-
therapy should be considered to reduce the risk of
recurrence.
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